The Briefing Special Edition

Picture the patient. Thirty-eight, desk job, a car accident eleven years ago that "wasn't a big deal," headaches two or three times a week ever since. She has a neurologist, a medication list, and an MRI of her brain that says nothing. Nobody has put a hand on her neck.

Here is the frame I want you to carry through the rest of this. The headache is downstream. Somewhere back there was an injury, and it left the deep neck flexors weak and the suboccipitals, the upper trap, and the SCM guarding ever since. Those guarding muscles are not the villain. They are the fuse. They protect the nerve and the segment, they are what fails when the load gets too high, and they are the part that can actually heal. The nerve, the occipital nerve riding up through all that tissue, does not heal well, so the muscle takes the hit for it. When you understand that, the tight suboccipitals stop looking like the problem and start looking like the alarm.

Is that a story, or is there something to put a picture to? A bit of both, and I will be straight about which is which.

The imaging says the muscle is involved. An MRI T2-mapping study of 71 people found measurable signal changes in the upper trapezius of headache patients. A separate algometry study in 600 people found the lowest pressure pain thresholds over the skull in tension-type headache, and both headache groups were more sensitive even in body regions far from the head, which is your central sensitization tell. Then a blinded study put trained physios on 129 people and had them palpate the neck. They reproduced the patient's familiar head pain in about 69% of migraine patients and 72% of tension-type, against 23% of controls. Familiar pain. Not "that's tender," but "that's my headache."

None of those is a treatment trial. They are cross-sectional, they are associations, and the imaging is in a young sample. What they establish is modest and it is enough: the neck is measurably in this, and you can reproduce the headache with your hands. That is the door. The loading walks through it later.

Two honest complications before we go on, because they change how you talk to the patient. First, the scapula is part of this picture. A study this year split 144 people with neck pain by how their shoulder blade sits, and the group whose scapula rested in downward rotation had the most headache and dizziness, the most restricted upper-neck rotation, and the tenderest upper trap and levator. If the scapula sits low and the upper trap is screaming, that is a pattern, not a coincidence. Check it.

Second, and this one keeps me humble. The research group that has done the most work on trigger points and headache, Fernández-de-las-Peñas and colleagues, published their current position this year, and it is a caution aimed straight at people like me. Trigger points do reproduce the headache, yes. But treating them tends to buy short-term relief, and in chronic tension-type headache the pain is increasingly nociplastic, meaning the nervous system itself is turned up and the muscle is no longer the whole story. Phenotype the patient before you promise anything. The more chronic they are, the more the win lives in the reload and the less it lives in the needle. I will come back to that. I want it in your ear early.

Here is a thing that should give us confidence instead of a turf war. Medicine is already putting a needle in the back of the head and calling it a nerve block. The greater occipital nerve. A meta-analysis of 12 studies and 658 patients found occipital nerve blocks dropped migraine pain and cut headache days by about nine a month, and blocking closer to the source beat blocking farther away. Medicare, in the US, is restoring coverage for occipital nerve blocks starting late October, so you are about to see more of them, not fewer. The target is confirmed, over and over, by people who have never heard of the radiculopathic model.

We agree on the where. We disagree on the bet. A nerve block numbs the nerve. Botox paralyzes the muscle. I will tell you the case that turned me on this, and I have told it before because it still bothers me. A patient came to me after 19 Botox injections who had ended up needing a cervical collar, because you can only weaken a muscle so many times before it cannot hold the head up. Paralyzing a weak muscle makes it weaker. That is a different bet than making it capable.

And look, I am not here to trash the pharmacology. It works for people and I refer for it. But the ceiling is real. A review this year found that only about three in four patients are still on the newer anti-CGRP migraine drugs at a year, and most of the people who quit quit because the drug was not working. The drug is not the whole answer. Even the acupuncture literature, which I hold loosely, tells a careful story: a network meta-analysis found acupuncture matched preventive medication for migraine, and then did not separate from sham needling. Hold both of those. A needle holds its own against a pill. A needle also has a sham problem we should not pretend away.

One more, because it is the honest counterweight to my own enthusiasm. A critical review of the botulinum toxin literature argued that people over-read a Botox response as proof that the muscle is the generator. A drug working is not a mechanism. I think that is fair, and I think it cuts toward us as much as against us, because it means the muscle response you get from a needle is not self-evidently curative either. It is a window. What you do in the window is the treatment.

Everything above is assessment and reasoning. Here is where headache patients finally get what every other patient of ours gets, a number.

A case-control study measured deep neck flexor endurance in headache patients and controls. The patients held it for about 22 seconds. The controls, about 48. Extensor endurance was down too, and the craniovertebral angle, the forward-head measure, was worse. These are associations, not a trial, and I am ignoring the in-sample diagnostic numbers the authors got excited about. But think about what a stopwatch gives you here. A headache patient has spent years being told their pain is invisible, in their head, a chemistry problem. You put them supine, you run the craniocervical flexion test, you time their deep neck flexor hold, and suddenly there is a number on the table that is theirs. Twenty-two seconds. That is not invisible. That is a capacity you can train and re-time in two weeks.

Jull's work gives you the test to anchor it, the craniocervical flexion test, and it is the one I would learn cold if you treat necks. The companion measures from the scapula study pair with it: the flexion-rotation test for upper-neck rotation, and pressure thresholds at the upper trap and levator. Pick two or three, write them down, and you have your verify step.

This is the part everyone was waiting for, and it is the part where I have to be the most careful, because the evidence here is a mix and you can smell it when someone pretends otherwise.

Start with the one real controlled trial, because we finally have one to name. Dunning and colleagues ran a multicenter randomized trial, 142 patients with cervicogenic headache across 13 clinics in 10 states. One group got upper cervical and upper thoracic thrust manipulation plus electrical dry needling. The other got mobilization plus exercise. At three months the manipulation-plus-needling group had clearly bigger drops in headache intensity, frequency, and disability, with large effect sizes, and here is the number that stops me: 66% of them had stopped taking medication for their headaches entirely, against 21% in the other group. A secondary analysis this year looked at who responded, and found that chronicity, frequency, age, and disability did not predict success. Translation: do not write off the chronic, frequent, disabled headache patient. In this data they did as well as anyone.

Now the fine print, and read it before you quote the trial, because someone will check. The needle in that study came bundled with thrust manipulation, so you cannot pull the two apart and credit the needle alone. The comparison group differed on two things at once, thrust versus non-thrust and needling versus exercise, which muddies what exactly beat what. The authors teach these methods in a fellowship program, which they declared, and they took no funding. And it is a 2021 trial, not a hot-off-the-press one. None of that makes it a bad study. It is a genuine multicenter RCT with big effects, and it is the best controlled evidence we have that a package built around the neck and the needle beats a package that is not. Just cite it for what it is: the package, not the needle by itself.

How do I actually run one of these, with the consensus decision tree as the spine of it?

Screen first. Headache is a region with real red flags sitting next to it. A sudden worst-ever headache, a headache that changed character, new neurological signs, a headache with new nausea that tracks something in the environment, those are not yours and you know it. On the vascular fear specifically: a large matched cohort of around 431,000 per arm found cervical manipulation was not associated with higher dissection risk than an anti-inflammatory. That is reassurance about manipulation, not needling, and I am labeling it that way on purpose. Screening is still the job. Vertebral artery hypoplasia is a real low-flow setup in some necks, so the screen is not theater.

And one new rule I want burned in, from a case series of four people who got a spinal cord injury from a needle in the neck. Every single one felt an instantaneous electric shock the moment the needle went in, and then weakness, and the MRI lesion sat right on the needle's path. An electric shock is not a twitch. A twitch is the muscle answering you, a quick grab, sometimes a dull ache they recognize. A shock is sharp, it shoots, it travels, and their face changes. If you feel a shock reported, the needle does not go one millimeter further. Stop. None of those four were dry needled by a physio, and it does not matter. The lesson transfers. (Tuesday's issue carried this in full; it bears repeating here because the upper cervical spine is exactly where it applies.)

Candidacy and dosing. Decide how irritable the system is. The turned-up, nociplastic, every-day-headache patient gets a gentler dose and more of the reload and the education. The mechanical, reproduce-it-on-palpation patient can take more. Match the needle to the irritability, not to your enthusiasm.

Targets. The suboccipitals, the upper trap, the SCM, the splenius, plus whatever segment the neuro exam points you to. Central before peripheral: if the exam lights up a level, treat the level first, then the muscle. One anatomy note on the upper trap, because it is the muscle you will needle most. A mapping study found that the spot where patients localize their tender point, roughly the upper-middle interface on a line from C7 to the acromion, sits right over a small superficial neurovascular corridor. The author made no mechanism claim. I will make the practical one: palpate first, find the structure, and angle away from it.

The needle itself, and here is my honesty hedge. Why does a twitch plus a little e-stim change a headache? I do not fully know. My gut says we are using the language the nervous system actually speaks, which is electricity, and we are micro-dosing it right at the muscle that has been guarding for a decade. The twitch is the spinal cord answering. That is a gut-level mechanism, not a proven one, and I am not going to dress it up as more.

Then reassess, in the room. Re-palpate for the familiar pain. Re-run the stopwatch. Did the number move? That is the whole game, and it is the part most people skip. The Fernández-de-las-Peñas caution lands right here: in the chronic patient, the needle buys you a short-term window and not much more by itself, which is exactly why Part V exists.

If you only take one section of this special into Monday, I would honestly rather it be this one than the needling, and I say that as the guy whose bias is the needle.

The loading anchor is Jull's deep neck flexor training trial, a randomized study that showed training the deep neck flexors reduced cervicogenic headache. That is the one with the best pedigree in this whole special, and it is a loading study, not a needling one. Sit with that. The strongest evidence we have for fixing these headaches is building capacity in the muscle that was holding 22 seconds.

What goes in the program? Deep neck flexor endurance work, progressed off the craniocervical flexion test. The upper trap trained as the cervical stabilizer it is, which means loaded shrugs and rows, not endless chin tucks. And three exercises or fewer, because adherence is the whole ballgame and people do not do what you give them if you give them too much. If higher load is not tolerated yet, blood flow restriction is a reasonable bridge, with one caveat specific to this population: in a loading trial the blood flow restriction side threw a couple of headaches and a blood pressure spike as its adverse events, so screen the hemodynamics before you cuff a headache patient.

Here is the mechanism sentence I want you to be able to say to a patient, because it ties the whole special together. Your muscles have been guarding that nerve for years. They are the fuse, and the fuse has been blowing. We are going to reset it with the needle so it stops firing the alarm, and then we are going to make it strong enough that it does not need to guard anymore. Reset, reinforce, reload. The reset gets the attention. The reload is what sends you home.

And then the part that is a business decision disguised as a clinical one. End-of-episode them. Build the capacity, teach them the home program, and discharge them with "come back when you need me." Standing headache tune-ups every two weeks forever is a wonderful business model. It is not what we are meant to do.